Results

Total Results: 2,064 records

Showing results for "year".

  1. effectivehealthcare.ahrq.gov/sites/default/files/pdf/medicare-medication-use_research.pdf
    April 01, 2014 - We determined whether they had a psychiatric or a selected medical diagnosis during the reference year … (including prescription drugs) during the most recent month of dual eligibility for the reference year … Nonduals had Medicare coverage only for the reference year.23 Part D Status: We categorized Part D … All Part D indicates continuous Part D coverage during the reference year for all months of Medicare … No Part D indicates no Part D coverage during the reference year.
  2. effectivehealthcare.ahrq.gov/sites/default/files/pdf/weight-loss-surgery_research-protocol.pdf
    December 14, 2010 - Short-term outcomes: 1 year or best available post surgery intervention. … Short-term outcomes: 1 year or best available post surgery or medical intervention. … Comparators: N/A Outcomes: Short-term adverse events: • mortality • other Timing: 1 year … How do they compare to short-term outcomes (within 1 year from surgery)? … A 10-year Experience with Laparoscopic Gastric Banding for Morbid Obesity: High Long-Term Complication
  3. effectivehealthcare.ahrq.gov/sites/default/files/pdf/masks-appendix-table-b-3-version-1.xlsx
    February 01, 2020 - Observational studies of masks in healthcare settings Author Publication Year Title Date Retrieved Source
  4. effectivehealthcare.ahrq.gov/sites/default/files/adhd_disposition-comments.pdf
    October 01, 2011 - The analysis by Zuvekas showed a slight change from 97 to 01—a five year period in comparison to the … 10 year earlier steeper change. … Rewritten, Adderall is approved for ≥3 year olds in USA, and ≥6 year olds in Canada p 27 of 278 Peer … data was not seen later in the 8 year data. … By 3 year, MTA showed no difference among interventions but all improved from baseline.
  5. effectivehealthcare.ahrq.gov/sites/default/files/pdf/migraine-future_research.pdf
    April 01, 2013 - (I, O) • What is the long-term (>1 year) effectiveness of pharmacologic treatments for prevention of … (I, O) • What is the long-term (>1 year) effectiveness of pharmacologic treatments for prevention of … Population Adults with chronic migraine maintaining preventive treatment regimen for 1 year. … Intervention Preventive pharmacologic treatment of 1-year duration. … How many migraine patients need prolonged (>1 year) preventive treatment?
  6. effectivehealthcare.ahrq.gov/sites/default/files/related_files/disparities-quality-improvement_executive.pdf
    August 01, 2012 - term among minorities than among Whites, although the interaction was no longer significant after 1 year … Summary of effects on disparities in health outcomes associated with race or ethnicity Author, Year … Summary of effects on disparities in health outcomes associated with insurance status Author, Year, … Summary of effects on disparities in health outcomes associated with sex Author, Year, Study Design … Duration of studies was generally 1 year.
  7. effectivehealthcare.ahrq.gov/sites/default/files/related_files/child-growth-development-outcomes-protocol-amended.pdf
    November 18, 2024 - nutrition for infants is commercially prepared and regulated standard infant formula during the first year … cow milk, regardless of milk fat content, should not be included in an infant’s diet until after 1 year … Excel® for data extraction for each Key Question that includes study characteristics (e.g., author, year
  8. effectivehealthcare.ahrq.gov/sites/default/files/related_files/making-healthcare-safer-IV.pdf
    August 04, 2023 - In the United States, more than 2.8 million antimicrobial-resistant infections occur each year and … a comparison group, including pre-post studies), systematic reviews, published since 2019, the year … We will search PubMed and the Cochrane Library for systematic reviews published since 2019, the year … a single team member to confirm eligibility and prepare a summary of the study, including author, year … describe eligible systematic reviews, a single team member will prepare a summary including the author, year
  9. effectivehealthcare.ahrq.gov/sites/default/files/pdf/mental-illness-disparities_research-protocol.pdf
    July 01, 2015 - Among adults with an SMI in 2008, less than 60 percent had used mental health services in the previous year … What are potential long-term (10-year +) developments in this field? III. Methods 1. … Inclusion Exclusion Population All GQs § ≥ 18 years with SMIa currently or at any time during the past year … The following information will be obtained from each study, where applicable: author, year of publication
  10. Politi (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/politi.pdf
    May 29, 2025 -  multiple comorbidities • Colorectal Cancer Screening Options for patients over age 7 or with  < year
  11. effectivehealthcare.ahrq.gov/sites/default/files/related_files/breast-cancer-medications_surveillance.pdf
    July 01, 2012 - Evidence Table Article ID, Author, year Trial n Subjects Primary Outcome Duration Study Quality … -raloxifene (60 mg/day): 9.754 Postmenopausal women age >35 years, with a 5- year … -tamoxifen (20 mg/day): 9,736 -raloxifene (60 mg/day): 9.754 Postmenopausal women with a 5- year … : 2285 -placebo: 2275 Postmenopausal women age > 35 with one of the following factors: a 5- year … -tamoxifen (20 mg/day): 4739 -raloxifene (60 mg/day): 4717 Postmenopausal women with a 5- year
  12. effectivehealthcare.ahrq.gov/sites/default/files/related_files/suicidal-thoughts-young-people-amendement.pdf
    February 05, 2025 - We will limit the literature search to studies published after the year 2000 as older studies may not … Publications • Full-text peer-reviewed studies published in English • Studies published after the year … Registrar of Controlled Trials, Ovid® Cochrane Database of Systematic Reviews, and Scopus® from the year … we will develop a standardized data extraction form to extract study characteristics (i.e., author, year
  13. effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-d-surv-report-3-noninvasive-nonpharma_0.xlsx
    January 01, 2022 - surveillance reports for noninvasive nonpharmacological treatment for chronic pain report Author, Year … history of metastasizing cancer, unexplained unintended weight loss of 20 lbs. or more in the past year … B Age: 51 vs. 54 years Female: 94.7% vs. 100% Year since diagnosis: 8.16 vs. 8.98 years Baseline VAS … C Age: 52 (7.2) vs. 55 (7.2) vs. 56 (8.8) %Female: 100 vs. 100 vs. 100 Year of diagnosis: 2001 (7.5) … B Age: 53 (8) vs. 52.7 (8.5) %Female: 73 (97.3) vs. 74 (98.7) Year of diagnosis: 14 (9) vs. 13.1 (9.7
  14. effectivehealthcare.ahrq.gov/sites/default/files/diabetes-update-2015_executive.pdf
    January 01, 2015 - Five of the included observational studies lasted 1 year or less. … Of the 96 trials, 33 were at least 1 year in duration. … Most RCTs lasted a year or less, with only about 5 percent lasting more than 2 years. … Risk of stroke with thiazolidinediones: a ten-year nationwide population-based cohort study. … Three-year efficacy of complex insulin regimens in type 2 diabetes.
  15. effectivehealthcare.ahrq.gov/sites/default/files/related_files/evidence-summary-cer-195-uterine-fibroids-final.pdf
    December 01, 2017 - $5 billion, perhaps as much as $17 billion, with roughly $4,624 in costs per woman in the first year … These are rare but ominous: an average of 1,600 new cases occur in the United States each year. … They have poor outcomes with an average 5-year survival of 36 percent if cancer is not isolated to … Our models included the effect of the mean age of women in each study and the year in which it was … One small study reported improved bleeding patterns one year after surgery in 12 of 15 women.
  16. effectivehealthcare.ahrq.gov/sites/default/files/pdf/opioid-treatments-chronic-pain-protocol.pdf
    December 19, 2018 - effectiveness and risks of opioid therapy for chronic pain, focusing on studies with long-term (≥1 year … long-term opioid therapy for chronic pain, due to the absence of trials with followup of at least 1 year … up to 6 months), intermediate-term follow-up (6 to 12 months), and long-term follow-up (at least 1 year … up to 6 months), intermediate-term follow-up (6 to 12 months), and long- term follow-up (at least 1 year … up to 6 months), intermediate-term follow-up (6 to 12 months), and long-term follow-up (at least 1 year
  17. effectivehealthcare.ahrq.gov/sites/default/files/epc-disclosure-policy-form.pdf
    March 01, 2023 - Time period for financial interests disclosure: The instructions recommend a two year time window: 12 … For example, if financial COI from all sources over a two year time window (within the past year and … For example, if financial COI from all sources over a two year time window (within the past year and … Time period for financial interests disclosure: The instructions recommend a two year time window: 12 … For example, if financial COI from all sources over a two year time window (within the past year and
  18. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-194-disposition-comments-inhaled-corticosteroids.pdf
    March 19, 2018 - Nonetheless the overall trend is increasing (despite year to year differences in direction and amount … Public reviewer #1, Anonymous Time frame of the study (weeks, time of year) would also be informative … comparing it to high dose corticosteroid the evidence is week that it is a better choice in 5-11 year … As a pediatric asthma clinician, I found the discussion on the 0-4 year old use of intermittent ICS … found it difficult to understand whether there were sufficient numbers and evidence in the 12- 17 year
  19. effectivehealthcare.ahrq.gov/sites/default/files/frazee-presentation.pdf
    May 29, 2025 - pay the mortgage, and your kids stil l have to get ready for school, and you find out that your 15-­‐year … They schedule my cleanings twice  a year. Ninety-­‐nine percent of the time I show up. … something new with  a patient for a short period   of time. did a research study earlier this year
  20. effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-d-opioid-chronic-pain-surveillance-report-2.xlsx
    September 30, 2015 - Randomized controlled trials Author, Year Study Design Duration Setting Country Eligibility Criteria … Observational studies Author, Year Type of Study, Setting Eligibility Criteria Comparison Groups Population … vs 66.1 Baseline MME ≥150: 46.7 vs. 34.0 Benzodiazepine use: 29.6% vs. 37.5% No overdoses previous year … electronic medical records, ICD-9 CM codes Enrolled: 1,320 Analyzed: 1,320 Loss to followup: NA Age, sex, year

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: